SKI Market

Indian Indices

Sensex

78,205.98 639.82
( 0.82%)

Global Indices

Nasdaq

47,737.88 215.33
(0.45%)

Dow Jones

6,814.47 53.45
(0.79%)

Hang Seng

54,146.56 1,417.84
(2.69%)

Nikkei 225

10,249.54 -35.21
(-0.34%)

Forex

USD-INR

91.85 0.10
(0.11%)

EUR-INR

106.60 0.13
(0.12%)

GBP-INR

123.04 0.62
(0.51%)

JPY-INR

0.58 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Welcure Drugs & Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524661

INE331C01025

1.0860857

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

35.84

EPS(TTM)

Face Value()

Div & Yield %

0.29

Back

Ipca Laboratories Ltd - Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The 2Nd Quarter And Half Year Ended 30.09.2025

Oct 17,2025

Ipca Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results for the 2nd quarter and half year ended 30.09.2025

78,205.98 639.82 ( 0.82%)

47,737.88 215.33 (0.45%)

6,814.47 53.45 (0.79%)

54,146.56 1,417.84 (2.69%)

10,249.54 -35.21 (-0.34%)

91.85 0.10 (0.11%)

106.60 0.13 (0.12%)

123.04 0.62 (0.51%)

0.58 0.00 (-0.25%)